The overall goal of this study is to determine the mechanisms of tumor necrosis factor-alpha's (TNF's) anti-leukemic activity in vivo. TNF, a macrophage product, kills tumor cells in vitro and in vivo and is cytotoxic to virus-infected cells with inhibition of viral replication observed in some systems. In addition to anti-tumor/virus activities, TNF has been shown to be involved in cell regulatory functions including activation of the immune response and effects on hematopoietic progenitors in vivo. We have demonstrated that TNF significantly suppresses late-stage Friend virus (FV) leukemic erythroid progenitors (CFU-E) in vivo. Suppression of CFU-E leads to permanent regression when animals are treated with either TNF or TNF plus interferon-gamma (IFN-gamma). TNF also significantly suppresses CFU-E in normal animals resulting in anemia which is reversed by erythropoietin (EPO). TNF has no direct effect in vitro on normal, but is cytotoxic to virus infected cells. T and NK cells are not involved in TNF's hematopoietic effects, but L3T4+ cells appear to be required for TNF induced regression. Therefore, we propose to examine whether TNF's anti- erythroleukemic activity is the result of TNF's suppressive effect on normal erythroid progenitors or the result of a specific immunologic or anti-virus response.
The aims of this study include: 1) to determine the mechanisms of TNF's suppressive effect in vivo on late-stage erythropoiesis by evaluating whether a) erythroid cells lose or shed their TNF receptor as they differentiate, b) TNF acts on erythroid cells by affecting their interaction with EPO, and c) TNF acts indirectly through induction of another cytokine; 2) to examine the interaction between TNF and L3T4+ cells in the regression of erythroleukemia by up-regulation of IL-2 and TNF receptors, enhanced cytokine production, increased proliferation and enhanced class II antigen expression; 3) to determine whether TNF directly interferes with the replication of FV in macrophages and erythroblasts by changes in reverse transcriptase levels, viral protein expression, and the presence of viral-specific RNA; 4) to determine whether TNF induces INF in FV infected macrophages with a correlation to an anti-viral effect. These studies form the basis for analyzing the mechanisms of these diverse effects in vitro and in vivo with possible application to the therapeutic use of TNF or related cytokines for hematopoietic malignancies and diseases with a viral etiology.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
7R01CA045674-08
Application #
2091963
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Project Start
1989-09-01
Project End
1996-05-31
Budget Start
1994-06-01
Budget End
1996-05-31
Support Year
8
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Ophthalmology
Type
Schools of Medicine
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
McElwain, M C; Modzelewski, R A; Yu, W D et al. (1997) Vitamin D: an antiproliferative agent with potential for therapy of squamous cell carcinoma. Am J Otolaryngol 18:293-8
Pourbohloul, S C; Thurlow, S M; Furmanski, P et al. (1992) Induction of permanent regression of Friend virus (FV) leukemia by adoptive transfer of T helper and not T cytotoxic cells. Leuk Res 16:881-7
Chang, M J; Pourbohloul, S C; Yu, W D et al. (1992) Differential effect in vitro of tumor necrosis factor-alpha (TNF) on normal and virus-infected erythroid progenitors from Friend virus (FVA)-infected mice. Exp Hematol 20:1271-7
Johnson, C S; Pourbohloul, S C; Furmanski, P (1991) Negative regulators of in vivo erythropoiesis: interaction of IL-1 alpha and TNF-alpha and the lack of a strict requirement for T or NK cells for their activity. Exp Hematol 19:101-5
Johnson, C S; Chang, M J; Braunschweiger, P G et al. (1991) Acute hemorrhagic necrosis of tumors induced by interleukin-1 alpha: effects independent of tumor necrosis factor. J Natl Cancer Inst 83:842-8
Furmanski, P; Johnson, C S (1990) Macrophage control of normal and leukemic erythropoiesis: identification of the macrophage-derived erythroid suppressing activity as interleukin-1 and the mediator of its in vivo action as tumor necrosis factor. Blood 75:2328-34
Johnson, C S; Chang, M J; Thurlow, S M et al. (1990) Immunotherapeutic approaches to leukemia: the use of the Friend virus-induced erythroleukemia model system. Cancer Res 50:5682S-5686S
Johnson, C S; Braunschweiger, P G; Furmanski, P (1990) In vivo effects of recombinant human and murine interleukin-1 alpha (IL-1 alpha) on murine hematopoiesis. In Vivo 4:93-6
Johnson, C S; Cook, C A; Furmanski, P (1990) In vivo suppression of erythropoiesis by tumor necrosis factor-alpha (TNF-alpha): reversal with exogenous erythropoietin (EPO). Exp Hematol 18:109-13